Cabaletta Bio Inc (CABA)

Oct 05, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 05, 2026

Oct 05, 2026

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 05, 2026

Oct 05, 2026

Press Release: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Moomoo

Oct 05, 2026

Sep 21, 2026

Cabaletta Bio (Nasdaq:CABA)Stock Analysis - Simply Wall Street

Sep 21, 2026

Sep 14, 2026

$2.50 share warrants bring new cash to Cabaletta Bio (CABA) - Stock Titan

Sep 14, 2026

Sep 14, 2026

Cabaletta Bio raises $128.2 million from warrant exercises ahead of expiration - Investing.com

Sep 14, 2026

Sep 14, 2026

Form 8K Cabaletta Bio Inc For: 14 September By Investing.com - Investing.com UK

Sep 14, 2026

Sep 14, 2026

Cabaletta Bio warrant exercises bring $128.2M gross proceeds after June 2025 offering - TradingView

Sep 14, 2026

Sep 09, 2026

Cabaletta Bio at cantorfitzgerald healthcare conference: safety and scale By Investing.com - Investing.com Canada

Sep 09, 2026

Sep 09, 2026

Cabaletta Bio at cantorfitzgerald healthcare conference: safety and scale By Investing.com - Investing.com UK

Sep 09, 2026

Sep 08, 2026

Cactus Cuts Q3 Pressure Control Outlook on Expected Double-Digit Revenue Decline - Minichart

Sep 08, 2026

Sep 06, 2026

Will Cabaletta Bio (NASDAQ:CABA) Spend Its Cash Wisely? - Moomoo

Sep 06, 2026

Sep 06, 2026

CABA Stock Price and Chart — NASDAQ:CABA - TradingView

Sep 06, 2026

Sep 05, 2026

Cabaletta Bio Takes Autoimmune Cell Therapy Pitch to Investors - MyChesCo

Sep 05, 2026

Sep 02, 2026

TD Cowen Maintains Cabaletta Bio(CABA.US) With Buy Rating - Moomoo

Sep 02, 2026

Sep 01, 2026

CABA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $16 - GuruFocus

Sep 01, 2026

Sep 01, 2026

Cabaletta Bio to Participate in Upcoming Investor Conferences - Yahoo Finance

Sep 01, 2026

Aug 31, 2026

Morgan Stanley Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Aug 31, 2026

Aug 27, 2026

Cabaletta Bio Inc. (CABA) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com

Aug 27, 2026

Aug 25, 2026

Cabaletta (CABA) Earnings Reading: EPS Lands Above Forecast in the Current Update; Post-Report: Shares Finish 0.96% Down in the Available RecordProfit Growth Outlook - vinanet.vn

Aug 25, 2026

Aug 21, 2026

Blue Owl Capital Holdings LP Acquires New Holdings in Cabaletta Bio, Inc. $CABA - MarketBeat

Aug 21, 2026

Aug 20, 2026

WuXi Bio to offload chromatography unit; Cabaletta names another CDMO partner - Endpoints News

Aug 20, 2026

Aug 19, 2026

Cabaletta Targets 2027 BLA as Cell Therapy Trials Advance - MyChesCo

Aug 19, 2026

Aug 19, 2026

Cabaletta Bio (NASDAQ:CABA) Trading 10.3% HigherShould You Buy? - MarketBeat

Aug 19, 2026

Aug 18, 2026

Norges Bank Initiates New Position in Cabaletta Bio (CABA) With 8.7 Million Share Purchase - GuruFocus

Aug 18, 2026

Aug 18, 2026

Cabaletta Bio (CABA) Rallies 5% as Biotech Sentiment ImprovesForce Index - vinanet.vn

Aug 18, 2026

Aug 18, 2026

HC Wainwright Raises Earnings Estimates for Cabaletta Bio - MarketBeat

Aug 18, 2026

Aug 17, 2026

Cabaletta Bio (CABA) Reports Promising Phase 1/2 Data Amid Unpro - GuruFocus

Aug 17, 2026

Aug 16, 2026

668,563 Shares in Cabaletta Bio, Inc. $CABA Bought by GSA Capital Partners LLP - MarketBeat

Aug 16, 2026

Aug 16, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Aug 16, 2026

Aug 15, 2026

Wells Fargo Sticks to Their Hold Rating for Cabaletta Bio (CABA) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Cormorant Asset Management (CABA) discloses 10M-share Cabaletta Bio stake - Stock Titan

Aug 14, 2026

Aug 14, 2026

CABA Maintained by Wells Fargo -- Price Target Lowered to $3.00 - GuruFocus

Aug 14, 2026

Aug 14, 2026

Wells Fargo & Company Lowers Cabaletta Bio (NASDAQ:CABA) Price Target to $3.00 - MarketBeat

Aug 14, 2026

Aug 14, 2026

Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake - Stock Titan

Aug 14, 2026

Aug 14, 2026

Morgan Stanley Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Aug 14, 2026

Aug 14, 2026

Caballeta Bio (CABA) stake: Bain Capital Life Sciences reports 9.99% position - Stock Titan

Aug 14, 2026

Aug 13, 2026

Cabaletta Bio Inc (NASDAQ: CABA) Share Price, CABA Stock News, CABA Share Price & Updates - Kalkine

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio Releases Q2 2026 Financial Results - AlphaStreet

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio (NASDAQ:CABA) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio stock maintains Buy rating at TD Cowen on trial progress - Investing.com

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio stock maintains Buy rating at TD Cowen on trial progress - Investing.com Canada

Aug 13, 2026

Aug 13, 2026

Why is Cabaletta Bio stock sliding today? By Investing.com - Investing.com Australia

Aug 13, 2026

Aug 13, 2026

Why is Cabaletta Bio stock sliding today? By Investing.com - Investing.com South Africa

Aug 13, 2026

Aug 13, 2026

Why is Cabaletta Bio stock sliding today? - Investing.com

Aug 13, 2026

Aug 13, 2026

Why is Cabaletta Bio stock sliding today? By Investing.com - Investing.com Canada

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio Reports Q2 2026 Form 10-Q Highlighting Going Concern and Funding Challenges - Kalkine Media

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Aug 13, 2026

Cabaletta Bio (CABA) Q2 Earnings Beat Expectations; Market Focuses on Growth Potential Despite Losses - GuruFocus

Aug 13, 2026

Aug 13, 2026

Form 8K Cabaletta Bio Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026